Atlas Antibodies

What Atlas Antibodies does

Atlas Antibodies is a Stockholm-headquartered life science reagent company founded in 2006 as a commercial spin-off of the Human Protein Atlas (HPA) research initiative. The company develops, manufactures, and globally distributes primary antibodies, recombinant antigens, and protein interaction kits used by academic laboratories, pharmaceutical and biotechnology companies, and researchers in oncology, neuroscience, cell biology, and stem cell applications. Its portfolio centers on Triple A Polyclonals (over 22,000 validated antibodies derived from the HPA project), PrecisA Monoclonals, and PrEST Antigens (recombinant 50-150 amino acid fragments engineered to minimize cross-reactivity), complemented by two proprietary platforms: AtlasPlex for custom multiplex immunohistochemistry (3-plex or 5-plex panels from 12,000+ validated antibodies) and MolBoolean for immunofluorescent in situ detection of both free and interacting protein fractions. All SKUs are produced under an ISO 9001-certified quality system and undergo IWGAV-aligned enhanced validation including Genetic, Orthogonal, Independent Antibody, Recombinant Expression, and Migration Capture MS validation, with 500+ high-resolution images reviewed by pathologists per antibody across 44 normal human tissues and 20 cancer types.

The business runs on a direct e-commerce model through atlasantibodies.com, supplemented by a global distributor network, with all pricing published in SEK on a pay-as-you-go unit basis (antibodies at roughly 4,000-5,000 SEK, MolBoolean kits at 8,500-22,950 SEK, PrEST antigens around 2,500 SEK, and custom AtlasPlex kits delivered within two weeks). Marketing is content-led through a Knowledge Hub of white papers, webinars, FAQs, and educational content, amplified via LinkedIn, Instagram, and YouTube. The company has pursued inorganic expansion via acquisitions of HistoCyte Laboratories (February 2021, IHC tissue controls) and evitria (August 2021, recombinant antibody production), establishing ownership of key upstream capabilities. Leadership comprises CEO Nille Klæbel and Chairman Mathias Uhlén; founding equity traces to KTH Holding. Revenue, ownership details beyond KTH Holding, and any institutional investor composition are not publicly disclosed in available source material.

Name

Atlas Antibodies

Legal name

Atlas Antibodies

Website

https://atlasantibodies.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

51–100 employees

Short description

Atlas Antibodies is a Stockholm-based life science reagent company that develops, manufactures, and globally distributes rigorously validated primary antibodies, recombinant antigens, and protein interaction assay kits, serving academic, pharmaceutical, and biotechnology researchers across oncology, neuroscience, cell biology, and stem cell applications.

Ownership category

akta.pro rank

Product category

Life Science Research Reagents

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• Primary antibodies
• Protein research reagents
• Multiplex IHC assays
• PrEST control antigens
• Antibody validation services

Headquarters

HQ city

Bromma

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Antibody Product Sales: Sale of validated primary antibodies including Triple A Polyclonals (from Human Protein Atlas project) and PrecisA Monoclonals. Products sold in various unit sizes with standard pricing.
2. Assay Kit Sales: Sale of MolBoolean kits and AtlasPlex multiplex IHC assay kits for protein interaction analysis and multiplexed tissue analysis.
3. PrEST Antigen Sales: Sale of PrEST control antigens - recombinant protein fragments used as immunogens for antibody generation and as controls in antibody validation.
4. Custom/Co-development Services: Custom antibody development through co-development program for specific research needs beyond standard catalog offerings.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Atlas Antibodies develops, manufactures and globally distributes validated antibody reagents and protein-research kits for life-science research. The portfolio centers on Triple A Polyclonal Antibodies and PrecisA Monoclonal Antibodies (over 22,000 products), PrEST control antigens, and two proprietary assay kits: AtlasPlex for custom multiplex IHC and MolBoolean for in situ protein-protein interaction analysis. Production is ISO 9001 certified and every product is supported by Human Protein Atlas validation data.

Product overview

Atlas Antibodies offers a portfolio of advanced protein analysis reagents built around the Human Protein Atlas project. The core portfolio includes Triple A Polyclonal Antibodies (over 22,000 validated antibodies from the Human Protein Atlas) and PrecisA Monoclonal Antibodies, complemented by specialized application-focused antibodies for cancer, neuroscience, cell biology, and stem cell research. Key technology platforms include AtlasPlex for multiplex immunohistochemistry (allowing 3-plex or 5-plex custom panels from 12,000+ antibodies) and MolBoolean for in situ proximity analysis of protein-protein interactions. PrEST Antigens serve as the foundational immunogen components for antibody development. All products are ISO 9001 certified and come with extensive validation data including IHC, Western blot, ICC-IF, and ChIP applications.

Differentiator

Problem solved

Functional benefit

Brands

• AtlasPlex: Custom multiplex immunohistochemistry (IHC) assay kit enabling researchers to build panels with 3-5 biotinylated antibodies from a catalog of over 12,000 human genes.
• MolBoolean
• Triple A Polyclonals
• PrecisA Monoclonals
• PrEST Antigens

Products and services

• AtlasPlex Custom Multiplex IHC Kit A custom multiplex immunohistochemistry (IHC) assay kit that enables simultaneous detection of multiple protein targets in tissue samples using biotinylated antibodies, allowing researchers to build 3-plex or 5-plex panels drawn from a catalog of over 12,000 validated antibodies. It is intended for life-science researchers performing biomarker and tissue-profiling studies who need multiplex detection without secondary-antibody workflows.
• MolBoolean Kit An immunofluorescent in situ proximity assay kit for the analysis of protein-protein interactions that enables simultaneous detection and quantification of both free and interacting fractions of two protein targets in cells and tissue. It is built for researchers studying protein interactions in their native cellular context.
• Triple A Polyclonal Antibodies A catalog of more than 22,000 polyclonal antibodies developed through the Human Protein Atlas project and validated across IHC, Western blot, ICC-IF, and ChIP applications. Targeted at academic, pharmaceutical, and biotech researchers who need reproducibly validated antibodies for protein expression and biomarker studies.
• PrecisA Monoclonal Antibodies A line of monoclonal antibodies developed with enhanced validation standards, targeting specific proteins for research applications including IHC, Western blot, and ICC-IF. Designed for researchers requiring monoclonal specificity and reproducibility.
• PrEST Control Antigens Recombinant protein fragments, typically 50-150 amino acids in length, selected for minimal sequence similarity to other human proteins and used as immunogens for generating Triple A Polyclonals and PrecisA Monoclonals and as controls in antibody validation. Sold to researchers needing well-characterised control antigens for antibody specificity studies.

Quantifiable outcome

• Over 22,000 validated antibodies
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Abcam: One of the largest research antibody reagent providers globally (now owned by Danaher), offering primary antibodies, kits, and related reagents to academic and pharma researchers. Directly comparable catalog business, distribution model, and target customer base as Atlas Antibodies.
• Cell Signaling Technology (CST): Specialist in validated antibodies for signal transduction and cell biology research, with strict validation standards and an extensive catalog serving academic and pharma researchers. Highly comparable in focus on antibody specificity, validation rigor, and life science research customers.
• Santa Cruz Biotechnology: Long-established research antibody supplier offering a broad primary antibody catalog across multiple research applications. Directly comparable product mix and customer base, though positioned differently on validation depth.
• Bethyl Laboratories: Specialist antibody manufacturer focused on validation rigor and custom antibody services for academic and translational research. Comparable catalog model, emphasis on specificity, and target customer base as Atlas Antibodies.
• Novus Biologicals (Bio-Techne): Research antibody supplier (part of Bio-Techne) offering a broad primary antibody catalog to life science researchers. Directly comparable in product mix, distribution model, and customer segments.
• Rockland Immunochemicals: US-based custom and catalog antibody manufacturer serving academic, pharma, and diagnostics customers. Comparable antibody reagent business with custom development services similar to Atlas Antibodies' co-development program.

Emerging players

• Proteintech: Fast-growing privately held antibody manufacturer with a large catalog of validated polyclonal and monoclonal antibodies targeting the academic and translational research market. Comparable catalog strategy and emphasis on validation-driven positioning.

Broad incumbents

• Bio-Techne (R&D Systems): Diversified life science tools company offering antibodies (R&D Systems), proteins, ELISA kits, and assay reagents across a broad portfolio. Overlapping catalog with Atlas Antibodies but at significantly larger scale and across multiple product modalities.
• Thermo Fisher Scientific (Invitrogen Antibodies): Global life sciences conglomerate offering Invitrogen antibody reagents and related proteomics tools at massive scale. Overlaps with Atlas Antibodies on primary antibody catalog, serving the same academic and pharma researcher segments with a much broader portfolio.
• Merck (Sigma-Aldrich / MilliporeSigma): Major life science reagent supplier offering antibodies and biochemicals through the Sigma-Aldrich and MilliporeSigma brands. Comparable catalog product but as part of a much larger reagents and consumables portfolio serving research customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@atlasantibodiesvideo
• LinkedInlinkedin.com/company/atlas-antibodies
• Instagraminstagram.com/atlasantibodiesab
• Xx.com/atlasantibodies
• Facebookfacebook.com/atlasantibodies

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atlas Antibodies